M&A Deal Summary

inviCRO Acquires Core Clinical

On October 26, 2017, inviCRO acquired life science company Core Clinical

Acquisition Highlights
  • This is inviCRO’s 2nd transaction in the Life Science sector.
  • This is inviCRO’s 2nd transaction in the United States.
  • This is inviCRO’s 1st transaction in Pennsylvania.

M&A Deal Summary

Date 2017-10-26
Target Core Clinical
Sector Life Science
Buyer(s) inviCRO
Deal Type Add-on Acquisition

Target

Core Clinical

Doylestown, Pennsylvania, United States
Core Clinical, Inc. is a medical imaging core lab. Core Clinical develops new thinking in how we manage, analyze and deliver images and imaging data. Core Clinical, Inc. was established in 2016 and is based in Doylestown, Pennsylvania.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

inviCRO

Boston, Massachusetts, United States

Category Company
Founded 2008
Sector Software
DESCRIPTION

inviCRO is a provider of imaging-based solutions and image analysis software for research and drug development. inviCRO was founded in 2008 and is based in Boston, Massachusetts.


DEAL STATS #
Overall 3 of 3
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 3 of 3
State: Pennsylvania M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2017 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-09-12 Imanova

London, United Kingdom

Imanova Ltd. is a translational research company that specializes in applying positron emission tomography (PET) and magnetic resonance imaging (MRI) scanning techniques to improve productivity in early drug development and to help improve disease understanding. Imanova Ltd. was established in 2011 and is based in London, UK.

Buy -